|
GPX4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
9.64079999999923E-05 |
| Normal-vs-Stage3 |
1.65120000006347E-07 |
| Normal-vs-Stage4 |
1.937040E-03 |
| Stage1-vs-Stage2 |
5.495800E-01 |
| Stage1-vs-Stage3 |
9.914000E-01 |
| Stage1-vs-Stage4 |
9.168000E-01 |
| Stage2-vs-Stage3 |
5.267000E-01 |
| Stage2-vs-Stage4 |
7.095600E-01 |
| Stage3-vs-Stage4 |
8.982400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
3.77469999701674E-09 |
| Normal-vs-Asian |
2.574200E-01 |
| Caucasian-vs-AfricanAmerican |
9.984200E-01 |
| Caucasian-vs-Asian |
3.969400E-01 |
| AfricanAmerican-vs-Asian |
4.671000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
9.48730000116527E-08 |
| Male-vs-Female |
4.984400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.18229999965547E-07 |
| Normal-vs-Extreme_Weight |
1.22124532708767E-15 |
| Normal-vs-Obese |
1.02299946291851E-10 |
| Normal-vs-Extreme_Obese |
2.403900E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.960200E-01 |
| Normal_Weight-vs-Obese |
3.940400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.941800E-01 |
| Extreme_Weight-vs-Obese |
2.156800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.697400E-01 |
| Obese-vs-Extreme_Obese |
1.751570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.351600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.63347113613099E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
1.218220E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.594800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.094000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.438200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.195200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.401800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.042200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.23074900165921E-13 |
| Normal-VS-KIRP CIMP |
3.391600E-02 |
| Normal-VS-Unclassified PRCC |
2.0766999999644E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.568000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.286020E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.008600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.475800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.978970E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.443000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24209531549013E-11 |
| Normal-vs-N1 |
3.366800E-04 |
| Normal-vs-N2 |
2.301800E-01 |
| N0-vs-N1 |
5.511800E-02 |
| N0-vs-N2 |
2.879800E-01 |
| N1-vs-N2 |
8.555400E-01 |
|
|
